---
title: "Maccura's multiple projects selected for the Sichuan Province Innovative Medical Device Integration Application Pilot"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241337669.md"
description: "According to maccura, recently, the four major projects of fully automatic biochemical analyzers, chemiluminescence immunoassay analyzers, sample processing systems, and coagulation analyzers declared by maccura have successfully been selected as pilot projects for the integration and application of innovative medical devices in Sichuan Province"
datetime: "2025-05-22T02:40:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241337669.md)
  - [en](https://longbridge.com/en/news/241337669.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241337669.md)
generator: "portal-rs"
---

# Maccura's multiple projects selected for the Sichuan Province Innovative Medical Device Integration Application Pilot

According to maccura, recently, the four major projects of fully automatic biochemical analyzers, chemiluminescence immunoassay analyzers, sample processing systems, and coagulation analyzers declared by maccura have successfully been selected for the Sichuan Province Innovative Medical Device Integration Application Pilot

### Related Stocks

- [300463.CN](https://longbridge.com/en/quote/300463.CN.md)

## Related News & Research

- [Ecora Resources reports 1H results](https://longbridge.com/en/news/297762187.md)
- [F4 Mobile MT Strengthens Geophysical Targeting at Wales Lake | FFUCF Stock News](https://longbridge.com/en/news/297828927.md)
- [NeuroThera Labs seeks FDA orphan drug status for adult Tourette treatment SCI-110](https://longbridge.com/en/news/297783543.md)
- [07:15 ETTranspire Bio to Participate in Upcoming Healthcare Investor Conferences During September](https://longbridge.com/en/news/297775966.md)
- [11:00 ETCovationBio's Xatryx® Mass Production On Spec, to Debut First Non‑Food Bio‑Based Athletic Insole at NW Materials Show in the U.S.](https://longbridge.com/en/news/297804526.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**